Clinisys GLIMS is presented by Clinisys as a high-performance laboratory information system (LIS) intended to organize and automate laboratory processes from order entry and instrument control through results reporting, invoicing, and statistics. The vendor states that GLIMS can be used across private, hospital, specialist, and university laboratories and supports disciplines including haematology, clinical chemistry, serology, immunology, toxicology, microbiology, bacteriology, epidemiology, virology, blood transfusions, genetics, and clinical studies. Vendor pages also describe dedicated genetics and HLA transplant modules that can operate as standalone components or interface with LIS from other disciplines. [1][2][6]
Documented Core LIS Functions
Clinisys describes GLIMS as a system for automating and organizing laboratory processes according to user requirements. The stated scope includes order entry, instrument control, results reporting, invoicing, and statistics. Vendor materials claim that GLIMS enables laboratories to work more efficiently, save costs and resources, and offer enhanced service for requesters and patients, though no independent performance data are supplied in the reviewed documents. [1][6]
The vendor states that GLIMS supports automation of repetitive tasks and centralized control of Total Lab Automation instruments, robotic lines, and installations. Customizable workflows and user-configurable screens are described as part of the system. A Business Activity Monitor is documented as a feature for creating interactive management dashboards that visualize GLIMS data, giving laboratory managers access to steering information and bench staff real-time insight into work process status. [1][6]
Genetics Module and Workflow Scope
The GLIMS Genetics Module is described by Clinisys as combining a mature LIS with specialist genetic requirements. Vendor documentation states that the module covers the entire genetic spectrum, including next-generation sequencing, and supports editable workflows. Documented capabilities include a gene panel, variant results management, pedigree management, family management with a drawing pedigree solution, automated decision making, and a Clinical Genetics module with patient management and appointment tools. [1][2][5]
Clinisys states that the Genetics Module provides a dedicated screen for genetic examination covering PCR, RT-PCR, Sanger sequencing, NGS, FISH, karyotype, and microarray processes. The vendor says all common genetic technologies are fully supported and new technologies can be incorporated. The module is described as configurable for small laboratories or large, multi-site networked laboratories, and can work as a standalone solution or as part of a complete diagnostics LIS. [2][5]
Deployment and Configuration Considerations
Vendor materials describe GLIMS as cloud-ready and configurable for small, single-site laboratories through large, multi-site networks. The Genetics Module is documented as capable of running as a standalone solution with a gene panel and variant results management, interconnected with other laboratory information systems and interfaces to expert systems, or as part of a complete diagnostics LIS with a single instance across multiple sites. The HLA Transplant module is similarly described as able to work standalone or interface with LIS from other disciplines. [2][6][8]
The reviewed documents do not specify implementation timelines, hardware requirements, licensing costs, or migration procedures for GLIMS. A hypothetical demonstration could involve a multi-site genetics laboratory configuring a workflow for NGS variant review: an analyst would create a sample batch, assign a gene panel, review variant calls in the dedicated genetic examination screen, document family relationships in the pedigree tool, and release results to a connected EHR. Such a scenario would illustrate the documented modules, but no performance, accuracy, or clinical outcome should be inferred from it.
HLA Transplant Module
The GLIMS HLA Transplant module is documented as covering the human leucocyte antigen spectrum. Clinisys states that the module integrates technologies such as high-resolution typing and screening, supports monitoring for recipients and donors, and enables integration with national organ donation databases. The vendor describes automation and traceability features that give access to the latest status of requested HLA tests and adjust workflows according to the clinical context of the recipient or donor. [1][8]
Vendor documentation states that HLA Transplant interfaces with national and European donor management databases such as CRISTAL, SYRENAD, and Eurotransplant. The module is described as powered by JSON for data transmission and compatibility with other systems. Clinisys also documents MFI tracking within laboratory workflows, stating that technicians can access historical and current data and that labs tracking MFI values over time can identify abnormal variations. These are vendor descriptions of intended functionality rather than independently verified clinical outcomes. [8]
Interoperability and Integration Claims
Clinisys states that GLIMS supports common international standards such as IHE and can exchange data with third-party software applications. The vendor reports that at the 2009, 2010, 2012, and 2019 IHE Connectathons, Clinisys GLIMS successfully passed all tests for selected IHE profiles. An IHE Integration Statement is referenced in vendor materials, but the reviewed documents do not reproduce the statement's full contents. [1][6]
A separate Clinisys integration resource states that the company follows HL7 protocols and that host system, billing, outreach, interface engine, blood bank, instrument, and reference lab interfaces have become routine across installations. The resource lists numerous EHR, practice management, reference lab, and instrument interfaces, including Epic, Cerner, Allscripts, ARUP, and Quest. These lists appear in a general Clinisys integration document rather than a GLIMS-specific technical specification, so the exact applicability to every GLIMS deployment is not established in the reviewed sources. [3]
Versioned Features and Security Documentation
GLIMS 10 is described in a vendor leaflet as adding features for microbiology, biochemistry, and molecular biology. Documented additions include paperless microbiology workflow support, worklist support for microwell plate management, and specimen pooling for tests such as COVID-19 PCR. The leaflet also describes non-conformities registration for ISO 15189 compliance, a consult registration module, Business Activity Monitor, and full LOINC coding support. [5][7]
For data privacy and security, the GLIMS 10 leaflet states that transparent data encryption helps secure the laboratory database and that GLIMS 10 supports LDAP authentication for hospitals managing user rights centrally. The vendor references Clinisys ISO 27001 certification in connection with data security. These statements are vendor claims about version 10 capabilities and should not be read as a complete security assessment or regulatory certification of every GLIMS configuration. [5][7]